SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2627 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Unit DX. (3/23/17). "Press Release: Our Opening Event. The future looks bright for Science in Bristol". 2017-03-23
Regeneron Pharmaceuticals, Inc.. (3/22/17). "Press Release: U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis". Tarrytown, NY. 2017-03-22
Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-22
Microsaic Systems plc. (3/21/17). "Press Release: Audited Financial Results for the Year Ended 31 December 2016". 2017-03-21
Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2017-03-21
OptiBiotix Health plc. (3/21/17). "Press Release: Intention to Float SkinBioTherapeutics". 2017-03-21
Thermo Fisher Scientific Inc.. (3/21/17). "Press Release: Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain". London. 2017-03-21
Redx Pharma plc. (3/21/17). "Press Release: Final Results for the Year Ended 30 September 2016". 2017-03-21
Pulmocide Ltd.. (3/20/17). "Press Release: Pulmocide Raises $30 Million in Series B Financing. Funding to Progress Novel Wholly-owned Compounds for RSV and Pulmonary Aspergillosis". London. 2017-03-20
Eurofins Scientific UK. (3/17/17). "Press Release: Eurofins to Invest Millions in New UK Facility". 2017-03-17
AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease". 2017-03-17
Cell Medica Ltd.. (3/16/17). "Press Release: £60 Million Series C Financing to Advance Multiple Cancer Programmes". London. 2017-03-16
Adaptimmune Therapeutics plc. (3/15/17). "Press Release: Adaptimmune Broadens Executive Team". Philadeliphia, PA & Oxford. 2017-03-15
AstraZeneca plc. (3/14/17). "Press Release: Lynparza Phase III SOLO-2 Data Demonstrate Progression-free Survival Benefit in BRCA-mutated Ovarian Cancer as Maintenance Therapy". 2017-03-14
Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. 2017-03-13
Heptares Therapeutics Ltd.. (3/13/17). "Press Release: Heptares Enters Agreement with Daiichi Sankyo to Discover and Develop Novel, Small Molecules for the Treatment of Pain". London. 2017-03-13
Alimera Sciences, Inc.. (3/13/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in Spain". Atlanta, GA. 2017-03-13
University of Sheffield. (3/7/17). "Press Release: Keapstone Therapeutics Launched in World-first Partnership to Develop New Drugs for Parkinson’s". 2017-03-07
GlaxoSmithKline plc. (3/6/17). "Press Release: GSK’s MUSCA Study Shows Nucala (mepolizumab) Significantly Improves Quality of Life and Lung Function in Severe Asthma Patients with an Eosinophilic Phenotype". London. 2017-03-06
Prothena Corporation plc. (3/3/17). "Press Release: Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares". Dublin. 2017-03-03
Prothena Corporation plc. (3/2/17). "Press Release: Prothena Announces Public Offering of Ordinary Shares". Dublin. 2017-03-02
Merck KGaA. (3/2/17). "Press Release: NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC". Darmstadt. 2017-03-02
Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. 2017-03-02
PureTech Health plc. (3/2/17). "Press Release: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy". Boston, MA. 2017-03-02
Bicycle Therapeutics Ltd.. (3/2/17). "Press Release: Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference". Cambridge, MA & Cambridge. 2017-03-02
Arquer Diagnostics Ltd.. (3/1/17). "Press Release: Arquer Diagnostics Awarded Funding Under Innovate UK’s Biocatalyst Programme". Sunderland. 2017-03-01
GlaxoSmithKline plc. (3/1/17). "Press Release: GSK Confirms Closure of Agreement to Divest Anaesthesia Portfolio to Aspen". London. 2017-03-01
AstraZeneca plc. (2/28/17). "Press Release: FDA Approves Once-daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes". 2017-02-28
Oxford BioMedica plc. (2/28/17). "Press Release: Appointment of New Chief Financial Officer". Oxford. 2017-02-28
Oryzon Genomics S.A.. (2/27/17). "Press Release: Oryzon Presented New Preclinical Data of ORY-2001 Therapeutic Activity in Multiple Sclerosis at ACTRIMS-2017". Barcelona & Cambridge, MA. 2017-02-27
Congenica Ltd.. (2/27/17). "Press Release: Congenica Raises £8M ($10M) in Series B Financing Round to Drive International Expansion of Its Genome Analysis Business". Cambridge. 2017-02-27
Premaitha Health plc. (2/27/17). "Press Release: Completion of Yourgene Acquisition, Issue of Shares and Director Appointments". Manchester. 2017-02-27
AstraZeneca plc. (2/24/17). "Press Release: ZS-9 (sodium zirconium cyclosilicate) Receives Positive CHMP Opinion for the Treatment of Hyperkalaemia". 2017-02-24
Napp Pharmaceuticals Ltd.. (2/24/17). "Press Release: Napp Launches Truxima (rituximab), the First Biosimilar Monoclonal Antibody for the Treatment of Cancer, in the UK". Cambridge. 2017-02-24
PureTech Health plc. (2/24/17). "Press Release: PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference". Boston, MA. 2017-02-24
Storm Therapeutics Ltd.. (2/24/17). "Press Release: Storm Therapeutics Appoints CEO and Chairman". 2017-02-24
GlaxoSmithKline plc. (2/23/17). "Press Release: Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-controlled Asthma". London. 2017-02-23
Horizon Discovery Group plc. (2/23/17). "Press Release: Site Visit. Location – Cambridge". Cambridge. 2017-02-23
Apollo Therapeutics Fund. (2/22/17). "Press Release: Apollo Therapeutics – Funding of Four Initial Projects and Operational Update". Stevenage. 2017-02-22
Evotec AG. (2/21/17). "Press Release: »Lab282« Awarded First Projects. Oxford University and Evotec's Drug Discovery Partnership Launched Last November to Accelerate Drugs to Market Begins Making Awards". Hamburg. 2017-02-21
MorphoSys AG. (2/21/17). "Press Release: MorphoSys’s Subsidiary Lanthio Pharma Initiates First-in-Human Clinical Study with Lanthipeptide MOR107". Planegg. 2017-02-21
Genedata AG. (2/21/17). "Press Release: Genedata Expands into United Kingdom". Basel. 2017-02-21
Horizon Discovery Group plc. (2/20/17). "Press Release: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma". Cambridge. 2017-02-20
AstraZeneca plc. (2/20/17). "Press Release: AstraZeneca Enters Agreement with TerSera Therapeutics for Zoladex in the US and Canada". 2017-02-20
Centauri Therapeutics Ltd.. (2/20/17). "Press Release: Centauri Therapeutics Ltd Closes £2.5m Fundraising". London & Kent. 2017-02-20
Consilium Strategic Communications Ltd.. (2/20/17). "Press Release: Consilium Strategic Communications Advises Arix Bioscience plc on Its Successful £100 Million Fundraise and IPO on the Main Market of the London Stock Exchange". London. 2017-02-20
University of Warwick. (2/17/17). "Press Release: Molecular Phenomenon Discovered by Advanced NMR Facility". 2017-02-17
Almac Group Ltd.. (2/16/17). "Press Release: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations". Craigavon. 2017-02-16
Luxcel Biosciences Ltd.. (2/15/17). "Press Release: Luxcel Biosciences Ltd, Axiogenesis AG and BMG LABTECH GmbH Secure €2.5m European Investment to Develop and Launch Cell Metabolism Analysis Platform: »MetaCell-TM«". Cork. 2017-02-15
Quotient Clinical. (2/14/17). "Press Release: Quotient Clinical Announces Second US Acquisition – QS Pharma". Nottingham. 2017-02-14
Almac Group Ltd.. (2/14/17). "Press Release: RCSI and Almac Discovery Enter Research Collaboration to Target Therapy-resistant Cancer Tumours". Craigavon. 2017-02-14
Horizon Discovery Group plc. (2/14/17). "Press Release: Horizon Discovery Signs a Master Service Agreement with a Top Three Pharmaceutical Company". Cambridge. 2017-02-14
Prothena Corporation plc. (2/14/17). "Press Release: Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update". Dublin. 2017-02-14
Symbiosis Pharmaceutical Services Ltd.. (2/13/17). "Press Release: Scottish CMO Opens US Office". 2017-02-13
One Nucleus. (2/13/17). "Press Release: One Nucleus Announces New Director". Cambridge. 2017-02-13
Premaitha Health plc. (2/13/17). "Press Release: New Partnership with Major European Diagnostics Group". Manchester. 2017-02-13
Treos Bio, Ltd.. (2/13/17). "Press Release: Treos Bio Raises $8 Million in Private Investment Round". San Francisco, CA & London. 2017-02-13
Prothena Corporation plc. (2/8/17). "Press Release: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference". Dublin. 2017-02-08
Isogenica Ltd.. (2/6/17). "Press Release: Isogenica Announces New Licence Agreement with Maverick Therapeutics". Cambridge. 2017-02-06
Quotient Clinical. (2/6/17). "Press Release: Quotient Clinical Expands into USA through Acquisition of SeaView Research, the Specialist Clinical Pharmacology Business". Nottingham. 2017-02-06
AstraZeneca plc. (2/2/17). "Press Release: Full-year and Q4 2016 Results". 2017-02-02
Reading Scientific Services Ltd.. (2/2/17). "Press Release: RSSL Microbiology Laboratory Expansion". 2017-02-02
Optibrium Ltd.. (1/31/17). "Press Release: Optibrium Signs Agreement with Zastra Innovations for Distribution in India". Cambridge & Bengaluru. 2017-01-31
Heptares Therapeutics Ltd.. (1/31/17). "Press Release: Heptares Enters a New Research Collaboration under its "ORBIT" Initiative with the University of Cambridge". London & Cambridge. 2017-01-31
AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients". 2017-01-30
Qiagen N.V.. (1/30/17). "Press Release: Qiagen Hereditary and Rare Disease Solution Chosen by Genomics England". Hilden & London. 2017-01-30
Novo Nordisk A/S. (1/30/17). "Press Release: Novo Nordisk Enters Collaboration with University of Oxford on Type 2 Diabetes and Invests GBP 115m in New Research Centre". Bagsvaerd. 2017-01-30
Arcis Biotechnology Ltd.. (1/30/17). "Press Release: Arcis Biotechnology Awarded Funding under Innovate UK’s Biocatalyst Programme". Daresbury. 2017-01-30
Stallergenes Greer plc. (1/27/17). "Press Release: Stallergenes Greer Announces Positive Top-line Results of Phase 3 Study for Pediatric House Dust Mite-induced Allergic Rhinitis". 2017-01-27
Oxford BioTherapeutics Ltd.. (1/26/17). "Press Release: Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics". Alexandria, VA, San José, CA & Oxford. 2017-01-26
BioIndustry Assocation (BIA). (1/25/17). "Press Release: Innovative UK Companies Tackle Antimicrobial Resistance, Dementia and Long Term Disease Thanks to Government £26 Million Start-up Funding Awards". 2017-01-25
Horizon Discovery Group plc. (1/24/17). "Press Release: Horizon Discovery Trading Update". Cambridge. 2017-01-24
Microsaic Systems plc. (1/24/17). "Press Release: Appointment of Interim Chairman". 2017-01-24
Abzena plc. (1/20/17). "Press Release: Abzena Signs New ThioBridge License Agreement". Cambridge. 2017-01-20
GlaxoSmithKline plc. (1/19/17). "Press Release: Abbas Hussain to Leave GSK". London. 2017-01-19
GlaxoSmithKline plc. (1/19/17). "Press Release: Luke Miels Appointed President, Global Pharmaceuticals, GSK". London. 2017-01-19
Elementar UK Ltd.. (1/19/17). "Press Release: Isoprime Ltd Is Changing to Elementar UK". 2017-01-19
Congenica Ltd.. (1/17/17). "Press Release: Congenica Expands in North America with Strategic Appointment. Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer". Cambridge. 2017-01-17
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-13
Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. 2017-01-12
Intellia Therapeutics, Inc.. (1/11/17). "Press Release: Intellia Therapeutics Joins Genomics England’s Industry Consortium". Cambridge, MA & London. 2017-01-11
AstraZeneca plc. (1/10/17). "Press Release: AstraZeneca Receives EU Approval of Fasenra for Severe Eosinophilic Asthma". 2017-01-10
Macrophage Pharma Ltd.. (1/9/17). "Press Release: Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform". Windsor. 2017-01-09
Kymab Group Ltd.. (1/9/17). "Press Release: Kymab Expands Infectious Disease Programmes. Kymab Receives $9m Grant from the Bill & Melinda Gates Foundation to Fund Infectious Disease Research and Development". Cambridge. 2017-01-09
F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. 2017-01-09
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. 2017-01-09
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". 2017-01-06
Owlstone Medical Ltd.. (1/6/17). "Press Release: Owlstone Medical Announces $11.55m USD Fundraising". Cambridge. 2017-01-06
Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. 2017-01-05
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. 2017-01-05
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. 2017-01-05
Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. 2017-01-05
Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. 2017-01-04
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. 2017-01-04
Mundipharma International Ltd.. (12/20/16). "Press Release: CHMP Announces Positive Opinion for Biosimilar Rituximab Truxima and Mundipharma Has Secured Distribution Rights". Cambridge. 2016-12-20
Microbiotica Ltd.. (12/19/16). "Press Release: Cambridge Innovation Capital plc and IP Group plc Announce the Creation of Wellcome Trust Sanger Institute Spin-out company, Microbiotica". 2016-12-19
ERS Genomics Ltd.. (12/16/16). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology". Basel, et al.. 2016-12-16
Bicycle Therapeutics Ltd.. (12/15/16). "Press Release: Cancer Research UK and Bicycle Therapeutics Collaborate to Trial New Therapy for Advanced Solid Tumours". London, Cambridge & Cambridge, MA. 2016-12-15
Microsaic Systems plc. (12/13/16). "Press Release: Trading Update". 2016-12-13
Oxford Nanopore Technologies Ltd.. (12/12/16). "Press Release: Oxford Nanopore Announces £100M / $126M Fundraising". Oxford. 2016-12-12
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top